McMaster University and Doctor Evidence have collaborated on a joint product that constitutes a powerful standardized method for evaluating clinical evidence for life science and payer organizations.
Santa Monica, CA (PRWEB) July 19, 2011
McMaster University is partnering with Doctor Evidence to incorporate the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) evidence rating methodology into the Doctor Evidence Comparative Effectiveness platform. This joint product will streamline the process of assessing the quality of clinical evidence for Life Science and Payer organizations.
The GRADE methodology gives researchers a powerful, standardized method for evaluating evidence and making recommendations. The Doctor Evidence technology organizes and normalizes clinical data, making it easier to apply the GRADE methodology. The collaboration will yield a technology-enabled approach to every phase of systematic review development: reviewing literature, analyzing clinical data, and evaluating the quality of the evidence to provide recommendations and key findings.
“The integration of GRADE into the Doctor Evidence platform further enhances the value and utility of the methodology for healthcare researchers and decision makers,” says Dr. Holger Schunemann, Chair of McMaster’s renowned Department of Clinical Epidemiology and Biostatistics. “We expect that this partnership will accelerate the adoption of GRADE throughout healthcare and make GRADE more accessible to organizations outside of academia.”
“This partnership will support our mission to offer a comprehensive solution for evidence evaluation,” comments Robert Battista, CEO of Doctor Evidence. “Our product is perfectly designed to leverage the benefits of the GRADE methodology, while reducing the work effort our clients face in deploying new methods for evidence synthesis. We are excited to offer our clients this highly respected rubric for rating the quality of the body of evidence, which will lead to more precise clinical analysis and strengthen confidence in decision making.”
McMaster University, one of four Canadian universities listed among the Top 100 universities in the world, is renowned for its innovation in both learning and discovery. It has a student population of 23,000, and more than 140,000 alumni in 128 countries.
McMaster University is the intellectual home of evidence-based medicine. Researchers in the University’s department of clinical epidemiology developed the methodologies used to determine “best evidence” even coining the phrase “evidence-based.” Their insights have been adopted world-wide by healthcare practitioners looking to apply the best available scientific evidence to clinical decision making.
About Doctor Evidence
Doctor Evidence is the leader in the development of digital software technologies which process and deliver data from clinical studies to industries within life science, healthcare, academia and government. The Doctor Evidence database software enables users to conduct meta analyses with the highest level of accuracy, relevance and efficiency in the evidence based medicine market today.
Doctor Evidence is at the forefront of the healthcare comparative effectiveness and systematic review repository sector. With these services, payers, policy makers, medical societies and pharmaceutical organizations can use comparative evidence to differentiate efficacy, safety and epidemiological evaluations to inform coverage policy. Doctor Evidence is transforming the healthcare sector by providing a solution that reveals the “total cost-of-care” of any intervention in relation to its comparative efficacy and comprehensive care benefits.
For more information on the solutions available from Doctor Evidence, please visit us at http://www.doctorevidence.com.
- McMaster University Partners with Doctor Evidence to Launch an Integrated Evidence Grading Solution (prweb.com)
- McMaster University and DynaMed™ Partner to Identify Practice-Changing Evidence Across Medical Disciplines (prweb.com)
- New Guidelines Suggest DVT Prophylaxis Not Appropriate For All Patients (medicalnewstoday.com)
- Even When Silent, Irregular Heartbeat Linked to Stroke Risk, McMaster University Study (biospace.com)
- Faculty of 1000 and DynaMed™ Partner to Identify Practice-Changing Medical Research – Making Evidence-Based Medicine Actionable (prweb.com)
- Sugar for the Brain: Mechanism to Prevent Programmed Cell Death of Nerve Cells Deciphered, McMaster University Study (biospace.com)
- $30M donated to McMaster for stem cell therapies (cbc.ca)
- Cms (slideshare.net)
- New guidelines suggest DVT prophylaxis not appropriate for all patients (eurekalert.org)
- Evidence based medicine (slideshare.net)